Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2176
CALL
Magna International
MGA
$18.8B
| $14M | ﹤0.01% |
255,400
+22,500
| +10% | +$1.37M |
|
2177
PUT
iShares 1-3 Year Treasury Bond ETF
SHY
$25.5B
| $14M | ﹤0.01% |
169,300
-246,500
| -59% | -$20.4M |
|
2178
Integra LifeSciences
IART
$1.43B
| $14M | ﹤0.01% |
259,104
+59,329
| +30% | +$3.56M |
|
2179
United Therapeutics
UTHR
$21.4B
| $14M | ﹤0.01% |
59,353
-174,171
| -75% | -$35.4M |
|
2180
Bausch Health
BHC
$2.43B
| $14M | ﹤0.01% |
1,672,536
+517,280
| +45% | +$7.23M |
|
|
SWAV
2181
CALL
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $14M | ﹤0.01% |
73,100
+23,400
| +47% | +$4.13M |
|
2182
PUT
Kinder Morgan
KMI
$73.1B
| $14M | ﹤0.01% |
833,700
+32,100
| +4% | +$601K |
|
2183
Tenaris
TS
$27B
| $14M | ﹤0.01% |
543,712
-362,996
| -40% | -$11.2M |
|
2184
iShares 0-1 Year Treasury Bond ETF
SHV
$20.6B
| $13.9M | ﹤0.01% |
126,662
+3,427
| +3% | +$378K |
|
2185
MoonLake Immunotherapeutics
MLTX
$1.4B
| $13.9M | ﹤0.01% |
2,702,661
+2,003,765
| +287% | +$12.6M |
|
|
SQSP
2186
DELISTED
Squarespace, Inc.
SQSP
| $13.9M | ﹤0.01% |
664,700
+541,292
| +439% | +$11.6M |
|
2187
Installed Building Products
IBP
$6.39B
| $13.9M | ﹤0.01% |
167,185
+118,904
| +246% | +$10.2M |
|
2188
PUT
TripAdvisor
TRIP
$1.26B
| $13.9M | ﹤0.01% |
779,100
-297,800
| -28% | -$7.06M |
|
2189
VanEck Junior Gold Miners ETF
GDXJ
$8.49B
| $13.9M | ﹤0.01% |
+433,194
| New | +$17.8M |
|
|
BRSL
2190
CALL
Brightstar Lottery PLC
BRSL
$2.17B
| $13.8M | ﹤0.01% |
746,200
-21,300
| -3% | -$454K |
|
2191
Castle Biosciences
CSTL
$905M
| $13.8M | ﹤0.01% |
630,596
+443,589
| +237% | +$10.3M |
|
2192
AMN Healthcare
AMN
$1.34B
| $13.8M | ﹤0.01% |
126,100
-68,627
| -35% | -$6.79M |
|
2193
HEICO Corp Class A
HEI.A
$38.4B
| $13.8M | ﹤0.01% |
130,973
-9,416
| -7% | -$1.08M |
|
2194
PUT
Weyerhaeuser
WY
$17.7B
| $13.8M | ﹤0.01% |
416,500
-191,700
| -32% | -$7.31M |
|
2195
Remitly
RELY
$5.54B
| $13.8M | ﹤0.01% |
1,796,888
-889,030
| -33% | -$8.81M |
|
2196
Healthcare Services Group
HCSG
$1.48B
| $13.7M | ﹤0.01% |
789,124
+210,186
| +36% | +$3.62M |
|
2197
CALL
Unum
UNM
$14.8B
| $13.7M | ﹤0.01% |
403,800
+194,900
| +93% | +$6.6M |
|
2198
CALL
Invesco CurrencyShares Euro Currency Trust
FXE
$342M
| $13.7M | ﹤0.01% |
141,500
+37,200
| +36% | +$3.67M |
|
2199
Service Corp International
SCI
$11.5B
| $13.7M | ﹤0.01% |
198,085
+117,883
| +147% | +$8.06M |
|
2200
CALL
Insulet
PODD
$9.94B
| $13.7M | ﹤0.01% |
62,800
+24,700
| +65% | +$5.61M |
|
Similar funds
Citadel Advisors's Q2 2022 Portfolio in Review
As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
- Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.